is responsible for the operating strategy and overall performance of the company. He is a pharmaceutical industry executive with 25 years of progressive responsibility in contract manufacturing. Dr. Bryans came to Bryllan from Catalent Pharma Solutions where he was the VP/GM of the Blow Fill Seal business and senior leader of Catalent’s global sterile business unit. Dr. Bryans has held senior positions in Operations and Quality with significant experience in establishing compliant contract operations and supporting customers with their product development and growth. Dr. Bryans has worked with the FDA and other regulatory bodies to implement Quality systems plans to assure compliant site’s and business units. His international experience includes site expansions and managing cross-functional multi-national teams expanding global capacity in Europe, US, and South America, gaining site and product approvals for a wide range of global customers. He has a broad skill set of knowledge in the disciplines of P&L management, manufacturing/supply chain, Quality, and product development. Dr. Bryans holds a PhD in Chemistry from the University of Paisley in Glasgow, Scotland and US Patent Number 6,156,339, Process for preparing solid pharmaceutical formulation, approved in 2005.
has a background in manufacturing management and tech transfer, specializing in liquid and lyophilized presentations of parenteral drug products. He has extensive knowledge of manufacturing biologics, ranging from liquid hormone to lyophilized protein presentations. Mr. Pfitzenmaier was the Man-in-Plant at a Contract Manufacturing Organization (CMO), overseeing the successful production of a purified protein drug substance for the company’s most profitable drug product. At Bryllan, he leads all strategic and tactical activities of Manufacturing, New Product Development, Maintenance, and Customer Service.
Mr. Pfitzenmaier is a graduate of the University of Michigan with a B.S. in Cellular and Molecular Biology and a Masters in Pharmaceutical Engineering (M. Eng.).
has over 20 years of management experience in the pharmaceutical industry. At Bryllan he is responsible for all tactical and strategic operations of the Quality organization. The VP of Quality represents Bryllan internally and to external parties. Mr. Calcut has presented a number of international seminars on computer validation and has published an article on software validation. In addition, he has collaborated on articles dealing with the design of Bio-Safety Level 3 Laboratories.
Mr. Calcut holds a Bachelor of Science in Electrical Engineering.
has primary responsibility for strategic planning and management of the business and affairs of the company. He has owned and managed Vectech Pharmaceutical Consultants, a successful consulting firm serving the regulated medical products industries for the past 30 years. Mr. Pfitzenmaier has served the industry as a leader in ISPE as well as through establishing the Rapid Microbiology User’s Group. He has a number of publications and has been a frequent speaker at conferences worldwide.
Mr. Pfitzenmaier is a graduate of the University of Michigan with a BS in Industrial Engineering and a Masters of Business Administration (MBA).